A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This crucial cancer protector protein is frequently disabled in many types of tumors, resulting uncontrolled https://sound-social.com/story12302539/nanobodies-reactivate-tumor-suppressor-p53-new-potential-approach-for-tumor-treatment